Orthocell LtdASX: OCC

CelGro Study Results Open Up New US Market Access Strategy

· Issued by Orthocell Ltd

Filed with ASX · · 4 pages · English

• US 510(k) pilot animal study results indicate CelGro® facilitates superior nerve regeneration when compared to the market leading nerve repair device,restoring the sciatic nerve to its pre- injured state with no adverse reactions; • Pilot study provides critical insights into CelGro®’s mode of action in nerve regeneration and underpins the consistent restoration of arm and hand function to paral

Orthocell Ltd on 6ix

Earlier from Orthocell

Later from Orthocell

All Orthocell news releases